Schroder Investment Management Group
ICPT

Schroder Investment Management Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Schroder Investment Management Group’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-8,066
Closed -$1.33M – 1200
2016
Q3 		$1.33M Sell
8,066
-2,502
-24% -$394K ﹤0.01% 879
2016
Q2 		$1.51M Buy
+10,568
New +$1.54M ﹤0.01% 868
2014
Q4 		– Sell
-200
Closed -$47.3K – 1505
2014
Q3 		$47.3K Buy
+200
New +$51K ﹤0.01% 1279

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Schroder Investment Management Group's ICPT Position: Q4 2016 in Review

Schroder Investment Management Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2016, closing a stake of 8,066 shares — an estimated $1.33M sold.

Schroder Investment Management Group first reported a position in ICPT in Q3 2014 and held it in 3 quarters. The position peaked at $1.51M in Q2 2016. 159 funds tracked by Wall St. Rank hold ICPT as of Q4 2016.

  • Schroder Investment Management Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Schroder Investment Management Group sold 8,066 Intercept Pharmaceuticals, Inc. shares in Q4 2016, an estimated $1.33M.
  • Schroder Investment Management Group first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2014 and held it in 3 quarters.
  • Schroder Investment Management Group's Intercept Pharmaceuticals, Inc. position peaked at $1.51M in Q2 2016.
  • 159 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2016.

Based on Schroder Investment Management Group's 13F filing for Q4 2016, filed 10 Feb 2017.